Stellaromics
PrivateLast Round
Series B
Feb 11, 2025
Est. Valuation
$163M
Total Funding Raised
$105M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Stellaromics operates in Healthcare & Life Sciences and is based in Boston, Massachusetts. Its latest recorded funding round was a Series B round in February 2025.
Stellaromics is a biotechnology company that specializes in 3D spatial multi-omics technology for extracting high-resolution gene expression patterns from thick biological tissue samples.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Stellaromics Comparables
Compare Stellaromics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Moleculent | 88% | |
| Resolve Biosciences | 88% | |
| VIZGEN | 88% |
For institutional investors. Book with your work email.
Stellaromics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Feb 11, 2025 | ||||
| Series A | Nov 2, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Stellaromics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Stanford University | Series A, Series B |
| Plaisance Capital Management | Series A |
| Catalyst4 | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 10, 2026
Open roles increased to 11, doubling the trailing average.
- Jul 27, 2026
Open roles increased to 9, 3.5x the trailing average.
For institutional investors. Book with your work email.
Stellaromics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Stellaromics's valuation, stock price, and market status.
Is Stellaromics a public or private company?
Stellaromics is a private company.
What is the current stock price of Stellaromics?
Stellaromics is a private company, so its shares have no public market price. Caplight tracks Stellaromics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Stellaromics worth (valuation)?
Stellaromics's valuation is estimated at $163.0M based on funding round data.
Can I buy Stellaromics stock?
Stellaromics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Stellaromics's last funding round?
Stellaromics's most recent funding round was Series B on February 11, 2025.
Who are the main investors in Stellaromics?
Key investors in Stellaromics include Catalyst4.
Will Stellaromics IPO soon?
No public IPO plans have been announced for Stellaromics.
How can I track Stellaromics secondary market activity?
Caplight tracks bids, offers, and trades in Stellaromics's shares on secondary markets.